Call for Papers Antiphospholipid Syndrome Beyond Thrombosis – Frontiers-Immunology
Frontiers-Immunology shared a post on LinkedIn:
“Call for Papers: Antiphospholipid syndrome – beyond thrombosis (Frontiers in Lupus)
‘Antiphospholipid syndrome – beyond thrombosis’ is now welcoming submissions that push APS research past the classic ‘clotting-only’ framing – especially where APS intersects with lupus.
APS is defined by thrombotic risk in the presence of antiphospholipid antibodies (aPL). But newer work suggests the biology is not purely coagulation-driven. Complement activation, immune–coagulation cross-talk, and organ-specific manifestations (including pregnancy morbidity and possible inflammatory contributors to APS nephropathy) point to mechanisms that may matter for outcomes — and for treatment choices.
This Research Topic focuses on what we need to understand next:
- Inflammation and complement activation as drivers of APS manifestations
- Therapies beyond long-term anticoagulation (including approaches for treatment-resistant disease, high-risk aPL patterns, or arterial thrombosis)
- Novel biomarkers for APS diagnosis and risk stratification
- Multidisciplinary strategies for obstetric APS management
- Implications of the 2023 ACR/EULAR classification criteria for diagnosis and treatment
- Genetic and epigenetic factors shaping APS pathogenesis and progression
- Risk of SLE development in patients with primary APS
- APS emergence in SLE patients who were initially serologically negative
If your work helps clarify how thrombotic and inflammatory pathways interact in APS, and what that means for patients, this collection is a strong fit, including original research, reviews, and case analyses.
Manuscript Summary deadline (optional): 1 February 2026
Manuscript deadline: 22 May 2026
Led by: Magdalena Celińska-Lowenhoff, Teresa Iwaniec, Chaim Putterman
In: Frontiers in Lupus
Submit here.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2026, 17:03Devyanshi Dixit: Rethinking Pelvic Pain, Endometriosis and Uterine Health Ahead of GFWH 2026
-
Oct 11, 2026, 16:53Arsiak Vartenian: Choosing Surrogacy After 6 Miscarriages Taught Me a Different Kind of Strength…
-
Oct 11, 2026, 16:47Nahla Kazim: Honored to Attend the 5th EHS International Obstetrics and Gynecology Conference
-
Oct 11, 2026, 16:42Karolina Nowak: Sperm DNA Methylation Variability and Pregnancy Outcomes
-
Oct 11, 2026, 16:37Cumulase vs. Hyase: Comparing Hyaluronidase Performance in Routine ICSI Practice – RBMO
-
Oct 11, 2026, 16:17Mamta Vernekar Dighe: Can Technology Make IVF Safer Without Replacing Human Vigilance?
-
Oct 11, 2026, 16:14Fiona Pathiraja-Møller: The Vital Sign Medicine Keeps Missing
-
Oct 11, 2026, 16:11Pauliina Valpas: The 1st of 3 Reflections on the AIFertility Conference in Beautiful Cascais
-
Oct 11, 2026, 16:09FIGO Pregnancy Passport – Designed for Women and Their Healthcare Providers
